یادداشتهای مربوط به کتابنامه ، واژه نامه و نمایه های داخل اثر
متن يادداشت
Includes bibliographical references and index.
یادداشتهای مربوط به مندرجات
متن يادداشت
THE DRUG DEVELOPMENT PROCESS AND THE GLOBAL PHARMACEUTICAL MARKETPLACE -- REGULATION OF HUMAN PHARMACEUTICAL SAFETY -- DATA MINING -- SCREENS IN SAFETY AND HAZARD ASSESSMENT -- FORMULATIONS, ROUTES, AND DOSAGE REGIMENS -- NONCLINICAL MANIFESTATIONS, MECHANISMS, AND END POINTS OF DRUG TOXICITY -- PILOT TOXICITY TESTING IN DRUG SAFETY EVALUATION -- REPEAT-DOSE TOXICITY STUDIES -- GENOTOXICITY -- QSAR TOOLS FOR DRUG SAFETY -- IMMUNOTOXICOLOGY IN DRUG DEVELOPMENT -- NONRODENT ANIMAL STUDIES -- DEVELOPMENTAL AND REPRODUCTIVE TOXICITY TESTING -- CARCINOGENICITY STUDIES -- HISTOPATHOLOGY IN NONCLINICAL PHARMACEUTICAL SAFETY ASSESSMENT -- IRRITATION AND LOCAL TISSUE TOLERANCE IN PHARMACEUTICAL SAFETY ASSESSMENT -- PHARMACOKINETICS AND TOXICOKINETICS IN DRUG SAFETY EVALUATION -- SAFETY PHARMACOLOGY -- SPECIAL CONCERNS FOR THE PRECLINICAL EVALUATION OF BIOTECHNOLOGY PRODUCTS -- SAFETY ASSESSMENT OF INHALANT DRUGS AND DERMAL ROUTE DRUGS -- SPECIAL CASE PRODUCTS -- SPECIAL CASE PRODUCTS -- PEDIATRIC PRODUCT SAFETY ASSESSMENT (2006 GUIDANCE, INCLUDING JUVENILE TOXICOLOGY) -- USE OF IMAGING, IMAGING AGENTS, AND RADIOPHARMACEUTICALS IN NONCLINICAL TOXICOLOGY -- OCCUPATIONAL TOXICOLOGY IN THE PHARMACEUTICAL INDUSTRY -- STRATEGY AND PHASING FOR NONCLINICAL DRUG SAFETY EVALUATION IN THE DISCOVERY AND DEVELOPMENT OF PHARMACEUTICALS -- THE APPLICATION OF IN VITRO TECHNIQUES IN DRUG SAFETY ASSESSMENT -- EVALUATION OF HUMAN TOLERANCE AND SAFETY IN CLINICAL TRIALS -- POSTMARKETING SAFETY EVALUATION -- STATISTICS IN PHARMACEUTICAL SAFETY ASSESSMENT -- COMBINATION PRODUCTS -- QUALIFICATION OF IMPURITIES, DEGRADANTS, RESIDUAL SOLVENTS, METALS, AND LEACHABLES IN PHARMACEUTICALS -- TISSUE, CELL, AND GENE THERAPY -- APPENDIX A: SELECTED REGULATORY AND TOXICOLOGICAL ACRONYMS -- APPENDIX B: DEFINITION OF TERMS AND LEXICON OF "CLINICAL" OBSERVATIONS IN NONCLINICAL (ANIMAL) STUDIES -- APPENDIX C: NOTABLE REGULATORY INTERNET ADDRESSES -- APPENDIX D: GLOSSARY OF TERMS USED IN THE CLINICAL EVALUATION OF THERAPEUTIC AGENTS -- APPENDIX E: COMMON VEHICLES FOR THE NONCLINICAL EVALUATION OF THERAPEUTIC AGENTS -- APPENDIX F: GLOBAL DIRECTORY OF CONTRACT PHARMACEUTICAL TOXICOLOGY LABS -- INDEX.
بدون عنوان
0
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
"Provides practical guidance to solve scientific and regulatory issues in preclinical safety assessment, early clinical drug development, and post-approval impurity issues"--Provided by publisher.
ویراست دیگر از اثر در قالب دیگر رسانه
عنوان
Drug safety evaluation.
شماره استاندارد بين المللي کتاب و موسيقي
9781119097396
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Drugs-- Testing.
موضوع مستند نشده
Drugs-- Toxicology.
موضوع مستند نشده
Drug Evaluation, Preclinical.
موضوع مستند نشده
Drug Evaluation.
موضوع مستند نشده
Product Surveillance, Postmarketing.
موضوع مستند نشده
Drugs-- Testing.
موضوع مستند نشده
Drugs-- Toxicology.
موضوع مستند نشده
MEDICAL-- Pharmacology.
مقوله موضوعی
موضوع مستند نشده
MED-- 071000
رده بندی ديویی
شماره
615/
.
19
ويراست
23
رده بندی کنگره
شماره رده
RA1238
سایر رده بندی ها
شماره رده
QV
771
نشانه اثر
G123d
2017
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )